(C) World Health Organization
This story was originally published by World Health Organization and is unaltered.
. . . . . . . . . .
Webinar: Launch of new antimalarial drug resistance strategy for Africa [1]
[]
Date: 2022-11-18
Artemisinin-based combination therapy (ACT) is the mainstay of malaria care in Africa, where the disease is by far the most prevalent. The treatment, introduced in the early 2000s, has played a major role in lowering the burden of malaria over the last 2 decades.
In recent years, however, WHO has been concerned by reports of emerging drug-resistant malaria in Africa. Parasites in some areas have developed partial resistance to artemisinin – the core compound of ACTs – and there are worrying signs that they may also be resistant to other drugs that are commonly partnered with artemisinin. Vigorous measures are needed to protect their efficacy.
On 18 November 2022, WHO will launch a new strategy to respond to the urgent problem of antimalarial drug resistance in Africa. The strategy is being released during World Antimicrobial Awareness Week, a global annual campaign to improve awareness of the growing threat of resistance to antibiotics and other medicines.
Date: 18 November 2022
Time: 10:30 CET
Language: Discussions in English with simultaneous interpretation in French
Programme
10:30 – Welcome and introductions by Dr Andrea Bosman, Director a.i., Global Malaria Programme, WHO (Moderator)
10:35 – Video message by Dr Tedros Adhanom Ghebreyesus, WHO Director-General
Introductory remarks and presentation of the Strategy to respond to antimalarial drug resistance in Africa
10:40 – Dr Haileyesus Getahun, Director, Department of Global Coordination and Partnership, Antimicrobial Resistance Division, WHO
10:45 – Representative from the WHO Regional Office for Africa (TBC)
10:50 – Dr Yvan Hutin, Director, Communicable Disease Control, WHO Regional Office for the Eastern Mediterranean
10:55 – Dr Pascal Ringwald, Coordinator, Global Malaria Programme, WHO
11:15 – Strategy to respond to antimalarial drug resistance in Africa: country and partners’ perspectives
Dr Aline Uwimana, Rwanda Biomedical Centre
Dr Corine Karema, Interim CEO, RBM Partnership to End Malaria
Dr Roopal Patel, Senior Malaria Advisor, Global Fund to Fight AIDS, Tuberculosis and Malaria
Dr David Walton, Coordinator, US President Malaria Initiative
11:30 – Questions & answers
11:55 – Closing remarks, Dr Andrea Bosman, Director a.i. Global Malaria Programme, WHO
[END]
---
[1] Url:
https://www.who.int/news-room/events/detail/2022/11/18/default-calendar/webinar-launch-of-new-antimalarial-drug-resistance-strategy-for-africa
Published and (C) by World Health Organization
Content appears here under this condition or license: Creative Commons CC-BY-NC-SA 3.0 IGO.
via Magical.Fish Gopher News Feeds:
gopher://magical.fish/1/feeds/news/who/
